We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$560M
AUM Growth
+$73.4M
Cap. Flow
+$17.4M
Cap. Flow %
3.11%
Top 10 Hldgs %
35.89%
Holding
404
New
56
Increased
149
Reduced
167
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 6.95%
2 Healthcare 3.72%
3 Financials 2.67%
4 Consumer Discretionary 2.34%
5 Communication Services 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
276
Allstate
ALL
$66.3B
$286K 0.05%
2,599
+132
+5% +$13K
FIVE icon
277
Five Below
FIVE
$13B
$286K 0.05%
1,635
-64
-4% -$9.48K
OKE icon
278
Oneok
OKE
$57.7B
$285K 0.05%
7,413
-899
-11% -$30.2K
ARKK icon
279
ARK Innovation ETF
ARKK
$6.38B
$284K 0.05%
+2,281
New +$247K
VBK icon
280
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.7B
$284K 0.05%
1,059
-99
-9% -$23.9K
ETN icon
281
Eaton
ETN
$178B
$283K 0.05%
2,358
+177
+8% +$20K
AMAT icon
282
Applied Materials
AMAT
$417B
$280K 0.05%
+3,249
New +$240K
FCOR icon
283
Fidelity Corporate Bond ETF
FCOR
$352M
$276K 0.05%
4,814
+943
+24% +$53.3K
NKE icon
284
Nike
NKE
$61.3B
$275K 0.05%
1,944
-143
-7% -$18.9K
TVTX icon
285
Travere Therapeutics
TVTX
$5.68B
$275K 0.05%
10,085
-368
-4% -$8.59K
GBT
286
DELISTED
Global Blood Therapeutics, Inc.
GBT
$272K 0.05%
6,288
+593
+10% +$29.2K
HYD icon
287
VanEck High Yield Muni ETF
HYD
$4.4B
$270K 0.05%
4,394
+110
+3% +$6.64K
TLT icon
288
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$266K 0.05%
1,688
-240
-12% -$38.1K
UGI icon
289
UGI
UGI
$7.54B
$266K 0.05%
7,616
-212
-3% -$7.42K
SCHD icon
290
Schwab US Dividend Equity ETF
SCHD
$107B
$265K 0.05%
+12,396
New +$251K
XLRN
291
DELISTED
Acceleron Pharma
XLRN
$262K 0.05%
2,050
-81
-4% -$9.5K
VGIT icon
292
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
$261K 0.05%
3,764
AES icon
293
AES
AES
$10.5B
$260K 0.05%
11,081
-346
-3% -$7.19K
C icon
294
Citigroup
C
$228B
$259K 0.05%
+4,202
New +$214K
NEO icon
295
NeoGenomics
NEO
$2.12B
$259K 0.05%
+4,805
New +$217K
ZM icon
296
Zoom
ZM
$31.1B
$259K 0.05%
767
+210
+38% +$93.6K
SRPT icon
297
Sarepta Therapeutics
SRPT
$1.92B
$258K 0.05%
+1,516
New +$225K
ALGN icon
298
Align Technology
ALGN
$12.3B
$257K 0.05%
+480
New +$216K
FEP icon
299
First Trust Europe AlphaDEX Fund
FEP
$532M
$255K 0.05%
+6,686
New +$239K
DLS icon
300
WisdomTree International SmallCap Dividend Fund
DLS
$1.07B
$253K 0.05%
3,719
-305
-8% -$19.4K

Similar funds

Calton & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Calton & Associates held 404 positions worth $560M, up 15% from $487M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Calton & Associates deployed $17.4M of net new capital in Q4 2020, opening 56 new positions and adding to 149 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Value ETF: 57,832 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $9.83M trimmed.

  • Calton & Associates's largest Q4 2020 buy was iShares S&P Small-Cap 600 Value ETF: 57,832 shares worth $4.7M.
  • Calton & Associates added most to iShares Core S&P Total US Stock Market ETF in Q4 2020, an estimated $11M increase.
  • Calton & Associates's biggest Q4 2020 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $9.83M.
  • Calton & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $3.79M.
  • Calton & Associates's ten largest holdings make up 36% of its $560M portfolio in Q4 2020.
  • Calton & Associates opened 56 new positions and closed 22 in Q4 2020.
  • Calton & Associates's portfolio value rose 15% quarter-over-quarter to $560M.

Based on Calton & Associates's 13F filing for Q4 2020, filed 25 Jan 2021.